Cost Evaluation of Panretinal Photocoagulation Versus Intravitreal Ranibizumab for Proliferative Diabetic Retinopathy

Ophthalmology - Netherlands
doi 10.1016/j.ophtha.2016.05.037
Full Text
Abstract

Available in full text

Categories
Ophthalmology
Date
Authors
Publisher

Elsevier BV

Related search

Evaluation of Visual Outcome in Proliferative Diabetic Retinopathy After Panretinal Photocoagulation

Journal of Evolution of Medical and Dental Sciences
2019English

Interim Safety Data Comparing Ranibizumab With Panretinal Photocoagulation Among Participants With Proliferative Diabetic Retinopathy

JAMA Ophthalmology
Ophthalmology
2017English

Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy With New Dense Vitreous Hemorrhage After Full Panretinal Photocoagulation

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2013English

Triamcinolone as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy

Archives of Ophthalmology
2006English

Pain Relief During Panretinal Photocoagulation for Diabetic Retinopathy

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2010English

Outcomes of Eyes Lost to Follow-Up With Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation vs Intravitreal Anti-Vascular Endothelial Growth Factor

Ophthalmology
Ophthalmology
2019English

Macular Thickness Changes Following Panretinal Photocoagulation in Patients With Severe Diabetic Retinopathy

Journal of Evolution of Medical and Dental Sciences
2018English

A Proposed Classification of Intraretinal Microvascular Abnormalities in Diabetic Retinopathy Following Panretinal Photocoagulation

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2020English

Photocoagulation and Diabetic Retinopathy.

BMJ
1979English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy